Effective myofibroblast dedifferentiation by concomitant inhibition of TGF-β signaling and perturbation of MAPK signaling

European Journal of Cell Biology

Volumn 92, Issue 12, 2013, Pages 363-373

  Kosla, Jan ^a   Dvorakova, Marta ^a   Dvorak, Michal ^a   Cermak, Vladimir ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

EGR4; FOXG1; Ha Ras(G12V); Microarrays; Myofibroblast; PDGFB; TGF

Indexed keywords

EGR4; FOXG1; HA-RAS(G12V); MICROARRAYS; MYOFIBROBLAST; PDGFB; TGF-Β;

ACTINS; ANIMALS; CELL DEDIFFERENTIATION; CHICK EMBRYO; MITOGEN-ACTIVATED PROTEIN KINASES; MYOFIBROBLASTS; PHORBOL ESTERS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84893761804     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2013.10.013     Document Type: Article

References (44)

1. Asano Y. Future treatments in systemic sclerosis. J. Dermatol. 2010, 37:54-70.
2. Bar-Peled M., Raikhel N.V. A method for isolation and purification of specific antibodies to a protein fused to the GST. Anal. Biochem. 1996, 241:140-142.
3. Bartunek P., Pichlikova L., Stengl G., Boehmelt G., Martin F.H., Beug H., Dvorak M., Zenke M. Avian stem cell factor (SCF): production and characterization of the recombinant His-tagged SCF of chicken and its neutralizing antibody. Cytokine 1996, 8:14-20.
4. Bhattacharyya S., Wei J., Melichian D.S., Milbrandt J., Takehara K., Varga J. The transcriptional cofactor nab2 is induced by tgf-Beta and suppresses fibroblast activation: physiological roles and impaired expression in scleroderma. PLoS ONE 2009, 4:e7620.
5. Cermak V., Kosla J., Plachy J., Trejbalova K., Hejnar J., Dvorak M. The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells. Cell. Mol. Life Sci. 2010, 67:3557-3568.
6. Crider B.J., Risinger G.M., Haaksma C.J., Howard E.W., Tomasek J.J. Myocardin-related transcription factors A and B are key regulators of TGF-beta1-induced fibroblast to myofibroblast differentiation. J. Invest. Dermatol. 2011, 131:2378-2385.
7. Demirci G., Nashan B., Pichlmayr R. Fibrosis in chronic rejection of human liver allografts: expression patterns of transforming growth factor-TGFbeta1 and TGF-beta3. Transplantation 1996, 62:1776-1783.
8. Flanders K.C. Smad3 as a mediator of the fibrotic response. Int. J. Exp. Pathol. 2004, 85:47-64.
9. Fuerstenberg S.M., Vennstrom B. Versatile avian retrovirus vectors. Anal. Biochem. 1993, 209:375-376.
10. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., Hornik K., Hothorn T., Huber W., Iacus S., Irizarry R., Leisch F., Li C., Maechler M., Rossini A.J., Sawitzki G., Smith C., Smyth G., Tierney L., Yang J.Y., Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5:R80.
11. Gharaee-Kermani M., Hu B., Phan S.H., Gyetko M.R. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast. Curr. Med. Chem. 2009, 16:1400-1417.
12. Gineitis D., Treisman R. Differential usage of signal transduction pathways defines two types of serum response factor target gene. J. Biol. Chem. 2001, 276:24531-24539.
13. Hecker L., Jagirdar R., Jin T., Thannickal V.J. Reversible differentiation of myofibroblasts by MyoD. Exp. Cell Res. 2011, 317:1914-1921.
14. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., Gabbiani G. The myofibroblast: one function, multiple origins. Am. J. Pathol. 2007, 170:1807-1816.
15. Holst C., Skerka C., Lichter P., Bialonski A., Zipfel P.F. Genomic organization, chromosomal localization and promoter function of the human zinc-finger gene pAT133. Hum. Mol. Genet. 1993, 2:367-372.
16. Houston P., Campbell C.J., Svaren J., Milbrandt J., Braddock M. The transcriptional corepressor NAB2 blocks Egr-1-mediated growth factor activation and angiogenesis. Biochem. Biophys. Res. Commun. 2001, 283:480-486.
17. Chen S.J., Ning H., Ishida W., Sodin-Semrl S., Takagawa S., Mori Y., Varga J. The early-immediate gene EGR-1 is induced by transforming growth factor-beta and mediates stimulation of collagen gene expression. J. Biol. Chem. 2006, 281:21183-21197.
18. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31:e15.
19. Ishiguro S., Akasaka Y., Kiguchi H., Suzuki T., Imaizumi R., Ishikawa Y., Ito K., Ishii T. Basic fibroblast growth factor induces down-regulation of alpha-smooth muscle actin and reduction of myofibroblast areas in open skin wounds. Wound Repair Regen. 2009, 17:617-625.
20. Kosla J., Dvorak M., Cermak V. Molecular analysis of the TGF-beta controlled gene expression program in chicken embryo dermal myofibroblasts. Gene 2013, 513:90-100.
21. Leask A. Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell Signal 2008, 20:1409-1414.
22. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ. Res. 2010, 106:1675-1680.
23. Liu C., Yao J., de Belle I., Huang R.P., Adamson E., Mercola D. The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1. J. Biol. Chem. 1999, 274:4400-4411.
24. Long X., Bell R.D., Gerthoffer W.T., Zlokovic B.V., Miano J.M. Myocardin is sufficient for a smooth muscle-like contractile phenotype. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1505-1510.
25. Lopez-Novoa J.M., Nieto M.A. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol. Med. 2009, 1:303-314.
26. Mandl M., Slack D.N., Keyse S.M. Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5. Mol. Cell Biol. 2005, 25:1830-1845.
27. McKaig B.C., Makh S.S., Hawkey C.J., Podolsky D.K., Mahida Y.R. Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta3. Am. J. Physiol. 1999, 276:G1087-G1093.
28. Mechta-Grigoriou F., Garel S., Charnay P. Nab proteins mediate a negative feedback loop controlling Krox-20 activity in the developing hindbrain. Development 2000, 127:119-128.
29. Miano J.M., Long X., Fujiwara K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am. J. Physiol. Cell Physiol. 2007, 292:C70-C81.
30. Muller H.J., Skerka C., Bialonski A., Zipfel P.F. Clone pAT 133 identifies a gene that encodes another human member of a class of growth factor-induced genes with almost identical zinc-finger domains. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:10079-10083.
31. Onichtchouk D., Chen Y.G., Dosch R., Gawantka V., Delius H., Massague J., Niehrs C. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 1999, 401:480-485.
32. Phan S.H. Biology of fibroblasts and myofibroblasts. Proc. Am. Thorac. Soc. 2008, 5:334-337.
33. Pohlers D., Brenmoehl J., Loffler I., Muller C.K., Leipner C., Schultze-Mosgau S., Stallmach A., Kinne R.W., Wolf G. TGF-beta and fibrosis in different organs - molecular pathway imprints. Biochim. Biophys. Acta 2009, 1792:746-756.
34. Reimann T., Hempel U., Krautwald S., Axmann A., Scheibe R., Seidel D., Wenzel K.W. Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells. FEBS Lett. 1997, 403:57-60.
35. Rodriguez C., Huang L.J., Son J.K., McKee A., Xiao Z., Lodish H.F. Functional cloning of the proto-oncogene brain factor-1 (BF-1) as a Smad-binding antagonist of transforming growth factor-beta signaling. J. Biol. Chem. 2001, 276:30224-30230.
36. Rosenbloom J., Castro S.V., Jimenez S.A. Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies. Ann. Intern. Med. 2010, 152:159-166.
37. Rupprecht H.D., Sukhatme V.P., Lacy J., Sterzel R.B., Coleman D.L. PDGF-induced Egr-1 expression in rat mesangial cells is mediated through upstream serum response elements. Am. J. Physiol. 1993, 265:F351-F360.
38. Russo M.W., Sevetson B.R., Milbrandt J. Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:6873-6877.
39. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3:Article3.
40. Spyrou G.E., Naylor I.L. The effect of basic fibroblast growth factor on scarring. Br. J. Plast. Surg. 2002, 55:275-282.
41. Svaren J., Sevetson B.R., Apel E.D., Zimonjic D.B., Popescu N.C., Milbrandt J. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol. Cell Biol. 1996, 16:3545-3553.
42. Wu M., Melichian D.S., de la Garza M., Gruner K., Bhattacharyya S., Barr L., Nair A., Shahrara S., Sporn P.H., Mustoe T.A., Tourtellotte W.G., Varga J. Essential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healing. Am. J. Pathol. 2009, 175:1041-1055.
43. Yoshida T., Hoofnagle M.H., Owens G.K. Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin. Circ. Res. 2004, 94:1075-1082.
44. Yoshida T., Sinha S., Dandre F., Wamhoff B.R., Hoofnagle M.H., Kremer B.E., Wang D.Z., Olson E.N., Owens G.K. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ. Res. 2003, 92:856-864.